Summary
A key intermediate, S-(−)-3-benzoylthio-2-methylpropanoic acid (1) was made in high optical purity by the lipase-catalyzed stereoselective esterification of racemic 1 with methanol in an organic solvent system. Among various lipases evaluated, Amano P-30 lipase from Pseudomonas sp. efficiently catalyzed the esterification of 1 to yield R-(+) methyl ester and unreacted S-(−) 1. A reaction yield of 40 mol% and an optical purity of 97.2% were obtained for compound 1 at a substrate concentration of 0.1 m (22 mg/ml). Lipase P-30 was immobilized on Accurel polypropylene (PP) and the immobilized enzyme was reused (23 cycles) in the esterification reaction without loss of enzyme acitivity, productivity or optical purity. Among various solvents evaluated, toluene was found to be the most suitable organic solvent and methanol was the best alcohol for the esterification of racemic 1 by immobilized lipase. Substrate concentrations as high as 1.0 m were used in the esterification reaction. When the temperature was increased from 28° C to 60° C, the reaction time required for the esterification of 0.1 m substrate decreased from 16 h to 2 h. On increasing the methanol to substrate molar ratio from 1:1 to 4:1, the rate of esterification decreased. A lipase fermentation using Pseudomonas sp. ATCC 21 808 was developed. In the batch-fermentation process, 56 units/ml of extracellular lipase activity was obtained. A fed-batch process using soybean oil gave a significant increase in the lipase activity (126 units/ml). Crude lipase recovered from the filtrate by ethanol precipitation and immobilized on Accurel PP was also effective: S-(−) compound 1 was obtained in 35 mol% yield and 95% optical purity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cushman DW, Ondetti MA (1980) Inhibitors of angiotensin-converting enzyme for treatment of hypertension. Biochem Pharmacol 29:1871–1877
Cushman DW, Cheung MS, Sabo EF, Ondetti MA (1977) Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16:5484–5491
Goodhue CT, Schaeffer JR (1971) Preparation of l(+) β-hydroxy-isobutyric acid by bacterial oxidation of isobutyric acid. Biotechnol Bioeng 13:203–214
Gu QM, Reddy DR, Sih CJ (1986) Bifunctional chiral synthons via biochemical methods VIII. Optically-active 3-aroyl-thio-2-methylpropionic acids. Tetrahedron Lett 27:5203–5206
Hasegawa J, Ogura M, Kanema H, Noda N, Kawaharada H, Watanabe K (1982) Production of d-β-hydroxyisogutyric acid from isobutyric acid by Candida rugosa and its mutant. J Ferment Technol 60:501–508
Jemal M, Cohen AT (1987) Determination of enantiomeric purity of Z-oxylysine by capillary gas chromatography. J Chromatogr 394:388–394
Moniot JL (1988) Preparation of N-[2-(mercaptomethyl) propionyl]-l-prolines. US patent application CN 88-100 862
Ondetti MA, Cushman DW (1981) Inhibition of renin-angiotensin system: a new approach to the theory of hypertension. J Med Chem 24:355–361
Ondetti MA, Krapcho J (1982) Mercaptoacyl derivatives of substituted prolines. US patent no. 4 316 906
Ondetti MA, Krbin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196:441–444
Sakimas A, Yuri K, Ryozo N, Hisao O (1986) Process for preparating optically active carboxylic acids and antipode esters thereof. US patent no. 4 629 701
Schimazaki M, Hasegawa J, Kan K, Nemura K, Nose Y, Kondo H, Ohashi T, Watanabe K (1982) Synthesis of captopril from an optically active β-hydroxy acid. Chem Pharm Bull 30:3139–3146
Sih CT (1987) Process for preparing optically active 3-acylthio-2-methyl propionic acid derivatives. European patent no. 87 264 125
Author information
Authors and Affiliations
Additional information
Offsprint requests to: R. N. Patel
Rights and permissions
About this article
Cite this article
Patel, R.N., Howell, J.M., Banerjee, A. et al. Stereoselective enzymatic esterification of 3-benzoylthio-2-methylpropanoic acid. Appl Microbiol Biotechnol 36, 29–34 (1991). https://doi.org/10.1007/BF00164694
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00164694